{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:49:19Z","timestamp":1787964559113,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"he key project of medical science and technology of Henan province in China","award":["SBGJ202102057"],"award-info":[{"award-number":["SBGJ202102057"]}]},{"name":"the science and technology project of Henan province in China","award":["212102310744"],"award-info":[{"award-number":["212102310744"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>A novel risk stratification model based on Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 and CT features was constructed and validated for predicting invasive pure ground-glass nodules (pGGNs) in China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Five hundred and twenty-six patients with 572 pulmonary GGNs were prospectively enrolled and divided into training (<jats:italic>n<\/jats:italic>\u2009=\u2009169) and validation (<jats:italic>n<\/jats:italic>\u2009=\u2009403) sets. Utilising the Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 framework and the types of GGN-vessel relationships (GVR), a complementary Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 was established, and the pGGNs were reclassified from categories 2, 3 and 4x of Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 into 2, 3, 4a, 4b, and 4x of cLung-RADS<jats:sup>\u00ae<\/jats:sup> v2022. The cutoff value of invasive pGGNs was defined as the cLung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 4a-4x. Evaluation metrics like recall rate, precision, F1 score, accuracy, Matthews correlation coefficient (MCC), and the area under the receiver operating characteristic curve (AUC) were employed to assess the utility of the cLung-RADS<jats:sup>\u00ae<\/jats:sup> v2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the training set, compared with the Lung-RADS 1.0, the AUC of Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 were decreased from 0.543 to 0.511 (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.002), and compared to Lung-RADS 1.0 and Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022, the cLung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 model exhibited the highest recall rate (94.9% vs 6.5%, 2.2%), MCC value (60.2% vs 5.4%, 6.3%), F1 score (92.5% vs 12.1%, 4.3%), accuracy (87.6% vs 23.1%, 19.5%), and AUC (0.718 vs 0.543, 0.511; <jats:italic>p<\/jats:italic>-value\u2009=\u20090.014, 0.0016) in diagnosing the invasiveness of pGGNs, and the similar performance was observed in the validation set.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The cLung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 can effectively predict the invasiveness of pGGNs in real-world scenarios.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Critical relevance statement<\/jats:title>\n            <jats:p>A complementary Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 based on the Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 and CT features can effectively predict the invasiveness of pulmonary pure ground-glass nodules and is applicable in clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Establishment and application of a multi-scale low-dose CT Lung cancer screening model based on modified lung-RADS1.1 and deep learning technology, 2022-KY-0137. Registered 24 January 2022. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.medicalresearch.org.cn\/search\/research\/researchView?id=a97e67d8-1ee6-40fb-aab1-e6238dbd8f29\" ext-link-type=\"uri\">https:\/\/www.medicalresearch.org.cn\/search\/research\/researchView?id=a97e67d8-1ee6-40fb-aab1-e6238dbd8f29<\/jats:ext-link>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 delayed lung cancer diagnosis for nodules appearing as pGGNs.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Lung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 showed lower accuracy and AUC than Lung-RADS 1.0.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>cLung-RADS<jats:sup>\u00ae<\/jats:sup> v2022 model effectively predicts the invasiveness of pulmonary pGGNs.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13244-025-01937-3","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T10:09:53Z","timestamp":1742724593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Construction and validation of a risk stratification model based on Lung-RADS\u00ae v2022 and CT features for predicting the invasive pure ground-glass pulmonary nodules in China"],"prefix":"10.1186","volume":"16","author":[{"given":"Qingcheng","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengrui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-3464","authenticated-orcid":false,"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,23]]},"reference":[{"key":"1937_CR1","first-page":"221","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF et al (2024) Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi 46:221\u2013231","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1937_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiol.10091808","volume":"258","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Berg CD et al (2011) The National Lung Screening Trial: overview and study design. Radiology 258:243\u2013253","journal-title":"Radiology"},{"key":"1937_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22690","volume":"22","author":"T Snowsill","year":"2018","unstructured":"Snowsill T, Yang H, Griffin E et al (2018) Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation. Health Technol Assess 22:1\u2013276","journal-title":"Health Technol Assess"},{"key":"1937_CR4","doi-asserted-by":"crossref","unstructured":"Tammem\u00e4gi MC, Katki HA, Hocking WG et al (2013) Selection criteria for lung-cancer screening. N Engl J Med 368:728\u2013736. Erratum in: N Engl J Med (2013) 369:394","DOI":"10.1056\/NEJMoa1211776"},{"key":"1937_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M17-2561","volume":"169","author":"TJ Caverly","year":"2018","unstructured":"Caverly TJ, Cao P, Hayward RA, Meza R (2018) Identifying patients for whom lung cancer screening is preference-sensitive: a microsimulation study. Ann Intern Med 169:1\u20139","journal-title":"Ann Intern Med"},{"key":"1937_CR6","unstructured":"WHO Classification of Tumours Editorial Board (2021) WHO classification of tumours: thoracic tumours, 5th edn. IARC, Lyon"},{"key":"1937_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21037\/jtd.2019.01.32","volume":"11","author":"J Wang","year":"2019","unstructured":"Wang J, Ma H, Ni CJ et al (2019) Clinical characteristics and prognosis of ground-glass opacity nodules in young patients. J Thorac Dis 11:557\u2013563","journal-title":"J Thorac Dis"},{"key":"1937_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lungcan.2011.09.002","volume":"76","author":"A Haro","year":"2012","unstructured":"Haro A, Yano T, Kohno M et al (2012) Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer. Lung Cancer 76:56\u201360","journal-title":"Lung Cancer"},{"key":"1937_CR9","first-page":"147","volume":"21","author":"G Jiang","year":"2018","unstructured":"Jiang G, Chen C, Zhu Y et al (2018) Consensus on the diagnosis and treatment of early lung adenocarcinoma with ground glass nodules in Shanghai Pulmonary Hospital (first edition). Chin J Lung Cancer 21:147\u2013159","journal-title":"Chin J Lung Cancer"},{"key":"1937_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/jcm9030672","volume":"9","author":"YH Lin","year":"2020","unstructured":"Lin YH, Chen CK, Hsieh CC et al (2020) Lymphadenectomy is unnecessary for pure ground-glass opacity pulmonary nodules. J Clin Med 9:672","journal-title":"J Clin Med"},{"key":"1937_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2019.10.009","volume":"468","author":"D Yang","year":"2020","unstructured":"Yang D, Liu Y, Bai C, Wang X, Powell CA (2020) Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett 468:82\u201387","journal-title":"Cancer Lett"},{"key":"1937_CR12","unstructured":"The American College of Radiology. Lung-RADS\u24c7 v2022. Available via https:\/\/www.acr.org\/-\/media\/ACR\/Files\/RADS\/Lung-RADS\/Lung-RADS-2022. Accessed 29 Sept 2022"},{"key":"1937_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/1759-7714.13199","volume":"10","author":"PH Chen","year":"2019","unstructured":"Chen PH, Chang KM, Tseng WC, Chen CH, Chao JI (2019) Invasiveness and surgical timing evaluation by clinical features of ground-glass opacity nodules in lung cancers. Thorac Cancer 10:2133\u20132141","journal-title":"Thorac Cancer"},{"key":"1937_CR14","doi-asserted-by":"publisher","first-page":"e41640","DOI":"10.2196\/41640","volume":"9","author":"L Guo","year":"2023","unstructured":"Guo L, Meng Q, Zheng L et al (2023) Lung cancer risk prediction nomogram in nonsmoking Chinese women: retrospective cross-sectional cohort study. JMIR Public Health Surveill 9:e41640","journal-title":"JMIR Public Health Surveill"},{"key":"1937_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.766939","volume":"11","author":"LW Guo","year":"2022","unstructured":"Guo LW, Lyu ZY, Meng QC et al (2022) Construction and validation of a lung cancer risk prediction model for non-smokers in China. Front Oncol 11:766939","journal-title":"Front Oncol"},{"key":"1937_CR16","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.21037\/qims-24-170","volume":"14","author":"Q Meng","year":"2024","unstructured":"Meng Q, Zheng C, Guo L et al (2024) Construction and validation of a risk score system for diagnosing invasive adenocarcinoma presenting as pulmonary pure ground-glass nodules: a multi-center cohort study in China. Quant Imaging Med Surg 14:4864\u20134877","journal-title":"Quant Imaging Med Surg"},{"key":"1937_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/CMAR.S232269","volume":"12","author":"Q Meng","year":"2020","unstructured":"Meng Q, Ren P, Gao P et al (2020) Effectiveness and feasibility of Complementary Lung-RADS Version 1.1 in risk stratification for pGGN in LDCT lung cancer screening in a Chinese population. Cancer Manag Res 12:189\u2013198","journal-title":"Cancer Manag Res"},{"key":"1937_CR18","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1007\/s00330-020-06776-y","volume":"30","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li C, Jin L et al (2020) Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction. Eur Radiol 30:3650\u20133659","journal-title":"Eur Radiol"},{"key":"1937_CR19","doi-asserted-by":"publisher","first-page":"065015","DOI":"10.1088\/1361-6560\/abe735","volume":"66","author":"X Hu","year":"2021","unstructured":"Hu X, Gong J, Zhou W et al (2021) Computer-aided diagnosis of ground glass pulmonary nodule by fusing deep learning and radiomics features. Phys Med Biol 66:065015","journal-title":"Phys Med Biol"},{"key":"1937_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0169-5002(02)00503-2","volume":"39","author":"CI Henschke","year":"2003","unstructured":"Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS (2003) Small stage I cancers of the lung: genuineness and curability. Lung Cancer 39:327\u2013330","journal-title":"Lung Cancer"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-01937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-01937-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-01937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T21:51:39Z","timestamp":1742766699000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-01937-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-01937-3","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,23]]},"assertion":[{"value":"28 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Medical Ethics Committee (2021-KY-0022) and complied with its ethical standards. Written informed consent was achieved by the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}